Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.59, $0.06 better than the analyst estimate of $2.53. Revenue for the quarter came in at $25.4 billion versus the consensus estimate of $25.38 billion.

GUIDANCE:

Johnson & Johnson sees FY2026 EPS of $10.95-$11.05, versus the consensus of $11.08. Johnson & Johnson sees FY2026 revenue of $101-101.4 billion, versus the consensus of $101.4 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.